Hematologic Malignancy Clinical Trial
Official title:
Reiki as a Complementary Therapy: A Pilot Study
This research is being done to test whether a complementary intervention, Reiki therapy, can
provide added benefits to the standard patient care. Reiki is method for stress reduction
that uses hand positions over and/or on the body to help people relax.
We are studying the effect of a 15-minute Reiki application compared to an intervention of
nursing presence without Reiki. We hope to find if Reiki can assist in relieving stress, and
improving patient outcomes. In the future we would like to offer complementary interventions
as an adjunct to our standard care for patients.
This pilot study is designed to test if a complementary therapy, Reiki, has an effect on
physiological and subjective measures of stress. This is a 2-arm randomized pilot study of
the use of Reiki therapy prior to a stressful event with a convenience sample of 40
participants who are newly diagnosed hematologic malignancy patients on the inpatient
service who will experience bone marrow aspirate post induction chemotherapy. Reiki therapy
is a non-invasive complementary therapy that can be used in addition to the standard of
care. The intervention group will receive a 15-minute Reiki session and the control group
will receive 15 minutes of nursing presence. Each study arm includes a brief item
questionnaire to rank subjective measures of pain, anxiety, and energy; saliva biological
markers related to stress-reduction; and measures of blood pressure, heart rate, and
respirations. The intervention group will receive a 15-minute intervention performed on the
inpatient unit prior to the bone marrow aspirate procedure. Data will be collected from
patients both before and after the intervention and before and after the bone marrow
aspirate. We will collect saliva samples from the control group and baseline data including
subjective measures of pain, anxiety and energy and measures of blood pressure, heart rate,
and respirations. The study nurse will maintain presence in the control participant's room
for 15-minutes after the initial measures.
Our research hypothesis is that there will be a change in the response to one or more
parameters of physiological or subjective measures for those patients receiving a Reiki
intervention when compared to those receiving standard of care plus the nurse presence in
room.
The null hypothesis is there will be no difference in response between the groups.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05400122 -
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer
|
Phase 1 | |
Recruiting |
NCT04889937 -
Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population
|
||
Not yet recruiting |
NCT05820126 -
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
|
Phase 2 | |
Active, not recruiting |
NCT04509765 -
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT
|
N/A | |
Not yet recruiting |
NCT06350994 -
Early Assessment of Cardiac Function After Treatment With CAR-T Cells
|
||
Withdrawn |
NCT04282174 -
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies
|
Phase 2 | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 | |
Withdrawn |
NCT03986086 -
MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
|
Phase 1/Phase 2 | |
Completed |
NCT02512666 -
Non Invasive Optical Imaging of WBC Count
|
N/A | |
Not yet recruiting |
NCT02193399 -
Physiotherapy in Hematopoietic Stem Cell Transplantation
|
N/A | |
Terminated |
NCT01846429 -
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain
|
Phase 1 | |
Terminated |
NCT01215981 -
Influenza Vaccine Post Allogeneic Transplant
|
N/A | |
Completed |
NCT00333190 -
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation
|
N/A | |
Withdrawn |
NCT04392128 -
Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)
|
Phase 2 | |
Recruiting |
NCT06102213 -
Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation
|
Phase 2 | |
Active, not recruiting |
NCT04552288 -
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies
|
Phase 2 | |
Completed |
NCT03654404 -
A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients
|
N/A | |
Recruiting |
NCT05384288 -
Response to Influenza Vaccination in Pediatric Oncology Patients
|
||
Recruiting |
NCT05084027 -
Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT
|
Phase 2 | |
Active, not recruiting |
NCT05180838 -
Remote Temperature Data for Early Detection of Febrile Neutropenia
|